562 related articles for article (PubMed ID: 33263511)
1. Frequency of and risk factors for carbapenem-resistant
Barber KE; Wagner JL; Larry RC; Stover KR
J Med Microbiol; 2021 Feb; 70(2):. PubMed ID: 33263511
[No Abstract] [Full Text] [Related]
2. [Clinical characteristics of carbapenem-resistant
Sun Y; Zheng H; Zhang JL; Yu LX; Wang B; Gao W; Cai JZ; Liu YH
Zhonghua Er Ke Za Zhi; 2020 Aug; 58(8):640-645. PubMed ID: 32842384
[No Abstract] [Full Text] [Related]
3. Effect of carbapenem resistance on outcomes of bloodstream infection caused by Enterobacteriaceae in low-income and middle-income countries (PANORAMA): a multinational prospective cohort study.
Stewardson AJ; Marimuthu K; Sengupta S; Allignol A; El-Bouseary M; Carvalho MJ; Hassan B; Delgado-Ramirez MA; Arora A; Bagga R; Owusu-Ofori AK; Ovosi JO; Aliyu S; Saad H; Kanj SS; Khanal B; Bhattarai B; Saha SK; Uddin J; Barman P; Sharma L; El-Banna T; Zahra R; Saleemi MA; Kaur A; Iregbu K; Uwaezuoke NS; Abi Hanna P; Feghali R; Correa AL; Munera MI; Le TAT; Tran TTN; Phukan C; Phukan C; Valderrama-Beltrán SL; Alvarez-Moreno C; Walsh TR; Harbarth S
Lancet Infect Dis; 2019 Jun; 19(6):601-610. PubMed ID: 31047852
[TBL] [Abstract][Full Text] [Related]
4. Multicenter Study of the Risk Factors for Colonization or Infection with Carbapenem-Resistant Enterobacteriaceae in Children.
Chiotos K; Tamma PD; Flett KB; Naumann M; Karandikar MV; Bilker WB; Zaoutis T; Han JH
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971864
[TBL] [Abstract][Full Text] [Related]
5. The epidemiology and risk factor of carbapenem-resistant enterobacteriaceae colonization and infections: Case control study in a single institute in Japan.
Asai N; Sakanashi D; Suematsu H; Kato H; Hagihara M; Nishiyama N; Koizumi Y; Yamagishi Y; Mikamo H
J Infect Chemother; 2018 Jul; 24(7):505-509. PubMed ID: 29548627
[TBL] [Abstract][Full Text] [Related]
6. Risk factors and outcomes associated with the isolation of polymyxin B and carbapenem-resistant Enterobacteriaceae spp.: A case-control study.
Teo JQ; Chang CW; Leck H; Tang CY; Lee SJ; Cai Y; Ong RT; Koh TH; Tan TT; Kwa AL
Int J Antimicrob Agents; 2019 May; 53(5):657-662. PubMed ID: 30880229
[TBL] [Abstract][Full Text] [Related]
7. Carbapenem-resistant Enterobacteriaceae in patients with bacteraemia at tertiary hospitals in South Africa, 2015 to 2018.
Perovic O; Ismail H; Quan V; Bamford C; Nana T; Chibabhai V; Bhola P; Ramjathan P; Swe Swe-Han K; Wadula J; Whitelaw A; Smith M; Mbelle N; Singh-Moodley A;
Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1287-1294. PubMed ID: 32124106
[TBL] [Abstract][Full Text] [Related]
8. Trimethoprim-sulfamethoxazole for the treatment of carbapenem-resistant Enterobacteriaceae (CRE) infections.
Bandali A; Bias TE
Infect Dis (Lond); 2019 Jun; 51(6):456-458. PubMed ID: 30856042
[No Abstract] [Full Text] [Related]
9. Clinical epidemiology of carbapenem-resistant enterobacteriaceae in community hospitals: a case-case-control study.
Lee GC; Lawson KA; Burgess DS
Ann Pharmacother; 2013 Sep; 47(9):1115-21. PubMed ID: 24259725
[TBL] [Abstract][Full Text] [Related]
10. Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis.
Zilberberg MD; Nathanson BH; Sulham K; Fan W; Shorr AF
BMC Infect Dis; 2017 Apr; 17(1):279. PubMed ID: 28415969
[TBL] [Abstract][Full Text] [Related]
11. Risk factors and outcomes of patients colonized with carbapenemase-producing and non-carbapenemase-producing carbapenem-resistant
Kassem A; Raed A; Michael T; Sagi O; Shimoni O; Borer A; Saidel-Odes L
Infect Control Hosp Epidemiol; 2020 Oct; 41(10):1154-1161. PubMed ID: 32624034
[TBL] [Abstract][Full Text] [Related]
12. The Likelihood of Developing a Carbapenem-Resistant
Tamma PD; Kazmi A; Bergman Y; Goodman KE; Ekunseitan E; Amoah J; Simner PJ
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31138574
[TBL] [Abstract][Full Text] [Related]
13. Carbapenem-resistant
Ruvinsky S; Voto C; Roel M; Deschutter V; Ferraro D; Aquino N; Reijtman V; Galvan ME; Motto E; García M; Sarkis C; Bologna R
Front Public Health; 2022; 10():983174. PubMed ID: 36091556
[TBL] [Abstract][Full Text] [Related]
14. Incidence and risk factors of carbapenem-resistant
Aleidan FAS; Alkhelaifi H; Alsenaid A; Alromaizan H; Alsalham F; Almutairi A; Alsulaiman K; Abdel Gadir AG
Expert Rev Anti Infect Ther; 2021 Mar; 19(3):393-398. PubMed ID: 32930620
[TBL] [Abstract][Full Text] [Related]
15. Clinical Risk Factors and Microbiological and Intestinal Characteristics of Carbapenemase-Producing
Yuan W; Xu J; Guo L; Chen Y; Gu J; Zhang H; Yang C; Yang Q; Deng S; Zhang L; Deng Q; Wang Z; Ling B; Deng D
Microbiol Spectr; 2022 Dec; 10(6):e0190621. PubMed ID: 36445086
[TBL] [Abstract][Full Text] [Related]
16. Subsequent carbapenem-resistant Enterobacteriaceae (CRE)-associated infections among hospitalized patients with CRE colonization: Impact of antibiotic use and other factors.
Khawcharoenporn T; Laichuthai W
Infect Control Hosp Epidemiol; 2020 Sep; 41(9):1084-1089. PubMed ID: 32475370
[TBL] [Abstract][Full Text] [Related]
17. Carbapenem-resistant Enterobacteriaceae infection in children less than one year old in an Asian medical center.
Yen CS; Hsiao HL; Lee CC; Tsai TC; Chen HY; Chen CL; Chiu CH
Pediatr Neonatol; 2023 Mar; 64(2):168-175. PubMed ID: 36241605
[TBL] [Abstract][Full Text] [Related]
18. Treatment options and clinical outcomes for carbapenem-resistant Enterobacteriaceae bloodstream infection in a Chinese university hospital.
Li C; Li Y; Zhao Z; Liu Q; Li B
J Infect Public Health; 2019; 12(1):26-31. PubMed ID: 30145151
[TBL] [Abstract][Full Text] [Related]
19. Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study.
McConville TH; Sullivan SB; Gomez-Simmonds A; Whittier S; Uhlemann AC
PLoS One; 2017; 12(10):e0186195. PubMed ID: 29023567
[TBL] [Abstract][Full Text] [Related]
20. The importance of active surveillance of carbapenem-resistant Enterobacterales (CRE) in colonization rates in critically ill patients.
Gomides MDA; Fontes AMS; Silveira AOSM; Matoso DC; Ferreira AL; Sadoyama G
PLoS One; 2022; 17(1):e0262554. PubMed ID: 35051212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
